1 Wilmut I, "Viable offspring derived from fetal and adult mammalian cells" 385 : 810-813, 1997
2 Hanna J, "Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin" 318 : 1920-1923, 2007
3 Jaenisch R, "Stem cells, the molecular circuitry of pluripo-tency and nuclear reprogramming" 132 : 567-582, 2008
4 Schuldiner M, "Selective ablation of human embryonic stem cells expressing a “suicide”gene" 21 : 257-265, 2003
5 Lyssiotis CA, "Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4" 106 : 8912-8917, 2009
6 김장환, "Reprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds" CELL PRESS 7 (7): 651-655, 201012
7 Draper JS, "Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells" 22 : 53-54, 2004
8 Carvajal-Vergara X, "Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome" 465 : 808-812, 2010
9 Soldner F, "Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors" 136 : 964-977, 2009
10 Cowan CA, "Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells" 309 : 1369-1373, 2005
1 Wilmut I, "Viable offspring derived from fetal and adult mammalian cells" 385 : 810-813, 1997
2 Hanna J, "Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin" 318 : 1920-1923, 2007
3 Jaenisch R, "Stem cells, the molecular circuitry of pluripo-tency and nuclear reprogramming" 132 : 567-582, 2008
4 Schuldiner M, "Selective ablation of human embryonic stem cells expressing a “suicide”gene" 21 : 257-265, 2003
5 Lyssiotis CA, "Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4" 106 : 8912-8917, 2009
6 김장환, "Reprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds" CELL PRESS 7 (7): 651-655, 201012
7 Draper JS, "Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells" 22 : 53-54, 2004
8 Carvajal-Vergara X, "Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome" 465 : 808-812, 2010
9 Soldner F, "Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors" 136 : 964-977, 2009
10 Cowan CA, "Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells" 309 : 1369-1373, 2005
11 Wernig M, "Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease" 105 : 5856-5586, 2008
12 Lee G, "Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs" 461 : 402-406, 2009
13 Huangfu D, "Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2" 26 : 1269-1275, 2008
14 Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors" 126 : 663-676, 2006
15 Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors" 131 : 861-872, 2007
16 Huangfu D, "Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds" 26 : 795-797, 2008
17 Taranger CK, "Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells" 16 : 5719-5735, 2005
18 도정태, "Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds" CELL PRESS 3 (3): 568-574, 200811
19 Dimos JT, "Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons" 321 : 1218-1221, 2008
20 Ebert AD, "Induced pluripotent stem cells from a spinal muscular atrophy patient" 457 : 277-280, 2009
21 Yu J, "Induced pluripotent stem cell lines derived from human somatic cells" 318 : 1917-1920, 2007
22 Stadtfeld M, "Induced pluripotency: history, mechanisms, and applications" 24 : 2239-2263, 2010
23 Yu J, "Human induced pluripotent stem cells free of vector and transgene sequences" 324 : 797-801, 2009
24 Hanna J, "Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs" 107 : 9222-9227, 2010
25 Warren L, "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA" 7 : 618-630, 2010
26 Okita K, "Generation of mouse induced pluripotent stem cells without viral vectors" 322 : 949-953, 2008
27 Nakagawa M, "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts" 26 : 101-106, 2008
28 Okita K, "Generation of germline-competent induced pluripotent stem cells" 448 : 313-317, 2007
29 Kim D, "Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins" CELL PRESS 4 (4): 472-476, 200906
30 윤태종, "Epigenetic memory in induced pluripotent stem cells" NATURE PUBLISHING GROUP 467 (467): 285-60, 201009
31 Hockemeyer D, "Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases" 27 : 851-857, 2009
32 Park IH, "Diseasespecific induced pluripotent stem cells" 134 : 877-886, 2008
33 Raya A, "Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells" 460 : 53-59, 2009
34 Kim JB, "Direct reprogramming of human neural stem cells by OCT4" NATURE PUBLISHING GROUP 461 : 649-U93, 2009
35 Ichida JK, "A small-molecule inhibitor of tgf- Beta signaling replaces sox2 in reprogramming by inducing nanog" 5 : 491-503, 2009